BC CANCER – KELOWNA

Serving people from the Boundary, Cariboo, Kootenay, Okanagan, Similkameen and Thompson regions of B.C., patients at BC Cancer – Kelowna have access to assessment and diagnostic services, chemotherapy, radiation therapy and supportive care. Patients can also take part in clinical trials and specific initiatives that are vital to the centre’s research programs.

To continue to propel leading-edge innovation in brachytherapy at BC Cancer – Kelowna and ensure patients in the Interior continue to have access to world-class care, the Foundation has embarked on a $3.5 million fundraising initiative to establish a Chair in Brachytherapy at the centre.

At BC Cancer – Kelowna, the centre is recognized for: 

  • Being provincial leaders in high dose rate (HDR) brachytherapy for breast, prostate and gynecological cancers, having changed standard of care
  • Developing computer software to improve radiation treatment
  • Providing a robust patient and family comfort program to enhance care

HDR Brachytherapy

BC Cancer Foundation has launched a $3.5M campaign to advance a new brachytherapy research program under the guidance of a new Chair in Brachytherapy at BC Cancer – Kelowna. This program, under world-class leadership, will propel brachytherapy at BC Cancer into a new era of excellence, generating knowledge to bring more effective therapies from the lab into the clinic, to benefit people facing a wide spectrum of cancers. This work will change the standard of care and save lives.

Brachytherapy is widely used to treat many types of cancer. The term brachytherapy refers to the placement of radioactive "seeds" or "sources" inside or next to a tumour. The seeds/sources deliver radiation directly to the tumour, sparing surrounding healthy tissue. Patients experience fewer side effects because healthy tissue is not dramatically affected by brachytherapy. In some cases, brachytherapy can even be used instead of surgery.

HDR (high dose-rate) Brachytherapy treatment is more versatile and precise than permanent seed implants. No radioactivity is left in the patient, instead a high intensity radioactive source traverses the tumour under ultrasound guidance.

You can support BC Cancer - Kelowna

DONATE TODAY

For more information, contact:

Pardeep Khrod
Executive Director
PH: 250.878.5490
pardeep.khrod@bccancer.bc.ca